|
Jan 11
|
What Happens When a Virus Becomes a Permanent Part of Your Genome?
|
|
Jan 9
|
Match Group, Juniper- HPE talks, Illumina: Trending Tickers
|
|
Jan 9
|
Illumina Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2023
|
|
Jan 9
|
Why Illumina Rallied 36.6% in December
|
|
Jan 9
|
Illumina unveils preliminary fourth-quarter revenue that tops estimates
|
|
Jan 9
|
Susan Tousi leaves Illumina to become CEO of liquid biopsy firm Delfi
|
|
Jan 8
|
Illumina (ILMN) Extends Partnership to Advance Cancer Test
|
|
Jan 5
|
Illumina expands collaboration with Janssen to advance molecular residual disease cancer test
|
|
Jan 4
|
Illumina to Announce Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 8, 2024
|
|
Jan 4
|
The Alliance for Genomic Discovery welcomes Bristol Myers Squibb, GSK, and Novo Nordisk
|
|
Dec 21
|
Nucleus Genomics Wants To Make Personalized Health Care a Reality
|
|
Dec 19
|
Heard on the Street: Illumina Nears the End of Its Painful Grail Saga
|
|
Dec 19
|
S&P 500 Gains and Losses Today: Enphase's Cost Cutting Charges Up Solar Stocks
|
|
Dec 19
|
Illumina To Webcast Upcoming Investor Conference
|
|
Dec 19
|
FTC, DOJ finalize merger guidelines that could impede healthcare M&A
|
|
Dec 19
|
Carl Icahn to initiate proxy battle with Illumina — again
|
|
Dec 19
|
A Lesser-Known Application of Genomics: Reducing Cow Burp Intensity
|
|
Dec 19
|
The 2023 stock market rally isn't just about 7 stocks anymore
|
|
Dec 19
|
Grail CEO predicts ‘transformative’ 2024 amid Illumina split
|
|
Dec 19
|
Could the ‘trustbusters’ be making a comeback?
|